FindTrial
Sign In

Expanded Access to ABBV-CLS-484

Status
AVAILABLE
Phases
Unknown
Study type
Expanded Access
Source
ClinicalTrials.gov
Registry ID
NCT06188975
Enrollment
Unknown
Registered
2024-01-03
Start date
Unknown
Completion date
Unknown
Last updated
2024-01-03

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Advanced Solid Tumor Cancer

Brief summary

This is an expanded access program (EAP) for eligible participants. This program is designed to provide access to ABBV-CLS-484 prior to approval by the local regulatory agency. Availability will depend on territory eligibility. A medical doctor must decide whether the potential benefit outweighs the risk of receiving an investigational therapy based on the individual patient's medical history and program eligibility criteria.

Interventions

DRUGDRUG: ABBV-CLS-484

Sponsors

Calico Life Sciences LLC
Lead SponsorINDUSTRY

Eligibility

Inclusion criteria

\-

Exclusion criteria

\-

Contacts

Primary ContactABBVIE CALL CENTER
abbvieclinicaltrials@abbvie.com847.283.8955

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026